Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The primary objective of this study is to compare the pharmacokinetic (PK) profiles of Albuterol Spiromax® and ProAir HFA after administration of a single inhaled dose of 180 mcg albuterol base from each product.
Epistemonikos ID: de72c407eee69cdc3726f42c4c2ce8b359ae6962
First added on: May 11, 2024